InvestSMART

Orthocell Limited (ASX:OCC)

ALERT: Price-sensitive ASX Announcement for OCC
Current share price for OCC : $0.800 0.08 (11.11%)+
Announcement
Release
3 Jul 2026 8:56AM
Price at Release
$0.720
Full Release
download
Summary
Orthocell Limited, a regenerative medicine company, announced the appointment of MediTime as the exclusive distributor for their nerve repair product, Remplir, in Thailand. This appointment follows regulatory approval from the Thai FDA, enabling Orthocell to access the approximately US$84 million Thai nerve repair market. MediTime, a specialist in orthopaedics and sports medicine, is well-positioned to support the distribution of Remplir through its established clinical education platform and logistics network. This collaboration builds on existing partnerships in Australia, New Zealand, and Singapore, and is part of Orthocell's broader Asian commercialisation strategy. The company remains focused on expanding its market presence, supported by a strong financial position with over A$48 million in cash as of March 2026.
Key Points
  • MediTime appointed as exclusive distributor for Remplir™ in Thailand.
  • Regulatory approval received from the Thailand FDA to sell Remplir.
  • Thailand represents a significant market with US$84 million potential.
  • MediTime has strong clinical education and distribution capabilities.
  • Orthocell's strategy includes expanding Asian distribution network.
  • Company maintains a strong funding position with A$48 million in cash.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.